Protein analysis technology
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
70
NCT06687941
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 11, 2025
Completion: May 31, 2028
Loading map...